SCN2A and epilepsy, early-onset: Moreover, the association of SCN2A mutations with early-onset epilepsy and intellectual disability, observed in 79 and 65 patients, respectively, corroborates findings from previous studies such as those by Ben-Shalom et al. and Christensen et al. [44,50].